Ibrutinib in patients with atrial fibrillation – the challenge of thromboembolic prophylaxis Cover

.blurhash-client-img { display: none !important; }

Ibrutinib in patients with atrial fibrillation – the challenge of thromboembolic prophylaxis

Romanian Journal of Internal Medicine

Volume 59 (2021): Issue 3 (September 2021)

By: Denisa-Corina Ciuculete, Raluca Alexandra Popescu and Gheorghe-Andrei Dan

Open Access

|Aug 2021

Authors

Denisa-Corina Ciuculete

University Hospital Colentina, Bucharest, Romania

“Carol Davila” University of Medicine, Bucharest, Romania

CDPC Research Department, Colentina Clinical Hospital, Bucharest, Romania

Raluca Alexandra Popescu

raluca.popescu@umfcd.ro

University Hospital Colentina, Bucharest, Romania

“Carol Davila” University of Medicine, Bucharest, Romania

Gheorghe-Andrei Dan

University Hospital Colentina, Bucharest, Romania

“Carol Davila” University of Medicine, Bucharest, Romania

CDPC Research Department, Colentina Clinical Hospital, Bucharest, Romania

DOI: https://doi.org/10.2478/rjim-2021-0015 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749

Journal RSS Feed

Language: English

Page range: 270 - 277

Submitted on: Mar 13, 2021

Published on: Aug 26, 2021

Published by: N.G. Lupu Internal Medicine Foundation

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

atrial fibrillation,

anticoagulation,

thromboembolic prophylaxis,

haemorrhagic risk

Related subjects:

Clinical medicine,

Internal medicine,

Internal medicine, other,

Gastroenterology,

© 2021 Denisa-Corina Ciuculete, Raluca Alexandra Popescu, Gheorghe-Andrei Dan, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 59 (2021): Issue 3 (September 2021)